Ester Falconer
About Ester Falconer
Ester Falconer serves as the Chief Technology Officer at AbCellera, a position she has held since 2021. With a background in research and development, she has extensive experience in the field of genetics and cell biology, holding a PhD from The University of British Columbia.
Work at AbCellera
Ester Falconer has been serving as the Chief Technology Officer at AbCellera since 2021. In this role, she oversees the technological advancements and strategic direction of the company. Prior to her current position, she held the role of Head of Research and Development at AbCellera from 2019 to 2020. Her tenure at AbCellera also includes a position as Senior Research Scientist from 2015 to 2018, where she contributed to various research initiatives in the field of biotechnology.
Education and Expertise
Ester Falconer earned her Doctor of Philosophy (PhD) in Genetics and Cell Biology from The University of British Columbia. Her educational background provides a strong foundation for her work in biotechnology and research. This expertise is reflected in her various roles within AbCellera and her previous experience at the BC Cancer Agency.
Background
Ester Falconer has a diverse background in research and development within the biotechnology sector. She worked as a Post-Doctoral Fellow at the BC Cancer Agency from 2005 to 2015, accumulating ten years of experience in cancer research. Her career path includes significant contributions to scientific research, particularly in antibody treatments and related technologies.
Achievements
Ester Falconer participated in a panel discussion titled 'The Promise of Antibody Treatments Across Disease States' at SynBioBeta's first ever BioPharma Day. This engagement highlights her involvement in discussions surrounding advancements in antibody therapies and their applications in various disease states, showcasing her commitment to sharing knowledge within the scientific community.